Harmonization Between NMPA and ICH Guidelines: What Global Teams Must Do Differently for China Making ICH Work in China: A Practical Playbook for NMPA-Aligned Development and Submissions Why NMPA–ICH Harmonization Matters Now: Global Standards, Local Proof, and the New Bar for “Ready” China’s pharmaceutical ecosystem has moved rapidly from a patchwork of local rules to a system that embraces the core logic of ICH, while keeping China-specific implementation details that teams must execute precisely. For sponsors, this is good news: familiarity with the ICH Q/E/M series translates into faster strategy formation, fewer duplicated studies, and cleaner global dossiers. But harmonization…